Eagle Pharmaceuticals Takes Equity Stake in, with Option to Acquire, Enalare Therapeutics to Advance Global Development of ENA-001, a Novel Agnostic Respiratory Stimulant
Benzinga
AUGUST 9, 2022
et al; PRODIGY Group Collaborators. Prediction of Opioid-Induced Respiratory Depression on Inpatient Wards Using Continuous Capnography and Oximetry: An International Prospective, Observational Trial. The Company anticipates a 2026 launch for post-operative respiratory depression, and community drug overdose thereafter. Field, D.J.,
40 
Let's personalize your content